Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Affinia Therapeutics received early financing of $60.0M on 2020-03-31.
| Series | Round size | Date |
|---|---|---|
| Series A | $60M | 03/2020 |
| Series B | $110M | 05/2021 |
| Investors | Security type |
|---|---|
| New Enterprise Associates (NEA) | Series A |
| Partners Innovation Fund | Series A |
| Lonza | Series A |
| F-Prime Capital | Series A |
| Atlas Venture | Series A |
| Alexandria Venture Investments | Series A |
| EcoR1 Capital, LLC | Series B |
| Woodline Partners LP | Series B |
| Avidity Partners | Series B |
| New Enterprise Associates (NEA) | Series B |
| F-Prime Capital | Series B |
| Atlas Venture | Series B |
| Farallon Capital Management | Series B |
| Lonza | Series B |
| Octagon Capital Advisors | Series B |
| Mass General Brigham Ventures | Series B |
| Perceptive Advisors | Series B |
| RA Capital Management | Series B |
| GV | Series B |
| TCG Crossover | Series B |
| Casdin Capital | Series B |
Affinia Therapeutics's top competitor, Voyager Therapeutics, earned an annual revenue of $80.0M.
Affinia Therapeutics's smallest competitor is Homology Medicines with revenue of $-6.7M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Dyno Therapeutics | - | $2.4M | 75 | - |
| Homology Medicines | - | ($6.7M) | 124 | - |
| Voyager Therapeutics | - | $80.0M | 123 | - |
| Passage Bio | - | $8.5M | 20 | - |
| Prevail Therapeutics | - | $74.3M | 66 | - |
| Fulcrum Therapeutics | - | $80.0M | 73 | - |
| Edgewise Therapeutics | - | $30,000 | 45 | - |
Zippia gives an in-depth look into the details of Affinia Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Affinia Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Affinia Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Affinia Therapeutics. The data presented on this page does not represent the view of Affinia Therapeutics and its employees or that of Zippia.
Affinia Therapeutics may also be known as or be related to Affinia Therapeutics.